Smart Bilayer Tablets with Integrated Technologies

The present inventive concept integrates bilayer tablets comprising acetylsalicylic acid and pseudoephedrine with cutting-edge technologies, such as AI, IoT, blockchain, and novel materials, to create a more powerful system for personalized medicine and optimized storage conditions.

The original patent disclosed bilayer tablets with improved dissolution properties, but limitations in terms of real-time monitoring, personalized dosing, and optimized storage conditions remained. The present inventive concept addresses these limitations by synergistically combining the patented bilayer tablets with distinct technologies.

The inventive concept comprises a system for monitoring and optimizing the storage conditions of bilayer tablets using IoT-enabled sensors and blockchain-based data storage. Additionally, AI-powered predictive analytics enable personalized dosing regimens based on individual patient characteristics. The tablets can be fabricated using 3D printing technology and incorporate novel materials with enhanced dissolution properties. A microfluidic device simulates in-vivo conditions, and a sensor array detects changes in tablet dissolution, predicting therapeutic efficacy. The inventive concept also includes a method for optimizing the formulation of bilayer tablets using AI-driven molecular modeling and IoT-enabled sensors.

The new claims introduce novel combinations of technologies, such as AI, IoT, blockchain, and novel materials, which are not obvious from the original patent. The inventive concept's integration of these technologies with the patented bilayer tablets provides a non-obvious solution to the limitations of the original patent.

Alternative embodiments of the inventive concept could include the use of other machine learning algorithms, different IoT-enabled sensors, or alternative blockchain-based data storage systems. Variations of the inventive concept could also incorporate other active pharmaceutical ingredients or different dissolution aids.

The inventive concept has significant commercial potential in the pharmaceutical industry, particularly in the areas of personalized medicine, real-time monitoring, and optimized storage conditions. Target industries include pharmaceutical manufacturers, healthcare providers, and medical research institutions.